Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04441528Phase 4Completed
Phase 4, randomised, double-blind trial of Hy-ter in Seborrheic Blepharitis, sponsored by Istanbul University-Cerrahpaşa. Primary endpoint: Blepharitis Symptom measure at 12 weeks. Started Nov 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04441528.